Small-Molecule APIs

May 01, 2008
Pharmaceutical Technology Europe
The pharmaceutical industry must address the release of nonbiodegradable APIs into the environment.
Apr 02, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
A changing regulatory environment is on the horizon for excipient suppliers and users.
Dec 01, 2007
Pharmaceutical Technology Europe
Lipid-based drug delivery systems — such as liposomes, micro-and nanoemulsions, self-emulsified drug delivery systems, and solid lipid micro-and nanoparticles — are becoming more popular because lipid materials are easily characterized, contain a high range of well-defined/tolerated surfactant molecules and can be developed for several administration routes.
Nov 01, 2007
Pharmaceutical Technology Europe
The crystalline structure of pharmaceutical solids can sometimes be altered during processing. X-ray powder diffraction and near infrared spectroscopy can be used to determine the amorphous and crystalline content of a model substance. The two techniques' precision, accuracy, detection limit and the speed of analysis are compared.
lorem ipsum